Your browser doesn't support javascript.
Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment.
Rottenberg, Yakir; Grinshpun, Albert; Ben-Dov, Iddo Z; Oiknine Djian, Esther; Wolf, Dana G; Kadouri, Luna.
  • Rottenberg Y; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel.
  • Grinshpun A; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Ben-Dov IZ; Breast Oncology Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Oiknine Djian E; Department of Nephrology and Hypertension, Hadassah Medical Center, Jerusalem, Israel.
  • Wolf DG; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Kadouri L; Clinical Virology Unit, Department of Microbiology and Infectious Disease, Hadassah Medical Center, Jerusalem, Israel.
JAMA Oncol ; 8(2): 300-301, 2022 02 01.
Article in English | MEDLINE | ID: covidwho-1527402
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: JAMA Oncol Year: 2022 Document Type: Article Affiliation country: Jamaoncol.2021.6764

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: JAMA Oncol Year: 2022 Document Type: Article Affiliation country: Jamaoncol.2021.6764